163 related articles for article (PubMed ID: 30718948)
1. Erratum: Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2019; 14():241. PubMed ID: 30718948
[TBL] [Abstract][Full Text] [Related]
2. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
Casas A; Montes de Oca M; Menezes AM; Wehrmeister FC; Lopez Varela MV; Mendoza L; Ramírez L; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2018; 13():1545-1556. PubMed ID: 29785104
[TBL] [Abstract][Full Text] [Related]
3. Erratum: Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2019; 14():245. PubMed ID: 30718950
[TBL] [Abstract][Full Text] [Related]
4. Erratum: Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2018; 13():3587. PubMed ID: 30464440
[TBL] [Abstract][Full Text] [Related]
5. Erratum: Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2017; 12():231. PubMed ID: 28138232
[TBL] [Abstract][Full Text] [Related]
6. Erratum: Russian guidelines for the management of COPD: algorithm of pharmacologic treatment [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2019; 14():243. PubMed ID: 30718949
[TBL] [Abstract][Full Text] [Related]
7. Erratum: Predicting frequent COPD exacerbations using primary care data [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2018; 13():2471. PubMed ID: 30147313
[TBL] [Abstract][Full Text] [Related]
8. Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study.
Montes de Oca M; Menezes A; Wehrmeister FC; Lopez Varela MV; Casas A; Ugalde L; Ramirez-Venegas A; Mendoza L; López A; Surmont F; Miravitlles M
PLoS One; 2017; 12(11):e0186777. PubMed ID: 29140978
[TBL] [Abstract][Full Text] [Related]
9. Erratum: Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2017; 12():859. PubMed ID: 28352166
[TBL] [Abstract][Full Text] [Related]
10. Erratum: The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2016; 11():417. PubMed ID: 27013872
[TBL] [Abstract][Full Text] [Related]
11. Erratum: Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2017; 12():229. PubMed ID: 28138231
[TBL] [Abstract][Full Text] [Related]
12. Erratum: Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2017; 12():227. PubMed ID: 28138230
[TBL] [Abstract][Full Text] [Related]
13. Erratum: Reduced nuclear translocation of serum response factor is associated with skeletal muscle atrophy in a cigarette smoke-induced mouse model of COPD [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2018; 13():603. PubMed ID: 29497288
[TBL] [Abstract][Full Text] [Related]
14. Erratum: Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial - Evaluation of Airway sGaw after treatment with tripLE [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2016; 11():1031-1033. PubMed ID: 27274224
[TBL] [Abstract][Full Text] [Related]
15. Erratum: The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2018; 13():3597. PubMed ID: 30464442
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum.
Sun XH; Yu HZ; Yang MM; Yang YM; Dang ZM
J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):192. PubMed ID: 26140254
[TBL] [Abstract][Full Text] [Related]
17. Erratum: Utility of the Morisky Medication Adherence Scale in gout: a prospective study [Corrigendum].
Patient Prefer Adherence; 2018; 12():527. PubMed ID: 29686486
[TBL] [Abstract][Full Text] [Related]
18. Erratum: Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017 [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2019; 14():115. PubMed ID: 30718947
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Association between patients' beliefs and oral antidiabetic medication adherence in a Chinese type 2 diabetic population [Corrigendum].
Patient Prefer Adherence; 2016; 10():1697. PubMed ID: 27660418
[TBL] [Abstract][Full Text] [Related]
20. Erratum: Adherence to diabetes medication among diabetic patients in the Bisha governorate of Saudi Arabia - a cross-sectional survey [Corrigendum].
Patient Prefer Adherence; 2019; 13():249. PubMed ID: 30804665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
